A study for a 2 year old boy who takes Depakene, Keppra - from FDA reports


Summary

90 males aged 2 (±5) who take the same drugs are studied. This is a personalized study for a 2 year old male patient who has Myoclonic Jerks. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Aug, 12, 2017

90 males aged 2 (±5) who take Depakene, Keppra are studied.


Number of reports submitted per year:

Depakene, Keppra for a 2-year old boy.

Information of the patient in this study:

  • Age: 2
  • Gender: male
  • Conditions: Myoclonic Jerks
  • Drugs taken:
    • Depakene (valproic acid)
    • Keppra (levetiracetam)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Weakness: 0 (0% of males aged 2 (±5) who take the drugs)
  • Bedridden: 0 (0% of males aged 2 (±5) who take the drugs)
  • Head Lag Abnormal: 0 (0% of males aged 2 (±5) who take the drugs)
  • Myoclonic Epilepsy: 1 (1.11% of males aged 2 (±5) who take the drugs)
  • Drowsiness, Hypersomnia, Sleepiness - During The Day, Somnolence: 0 (0% of males aged 2 (±5) who take the drugs)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common drug interactions over time

n/a

Top conditions involved for these people *:

  • Convulsion (10 people, 11.11%)
  • Infantile Spasms (7 people, 7.78%)
  • Status Epilepticus (5 people, 5.56%)
  • Poisoning Deliberate (2 people, 2.22%)
  • Grand Mal Convulsion (2 people, 2.22%)

Top co-used drugs for these people *:

  • Topiramate (9 people, 10.00%)
  • Lamotrigine (9 people, 10.00%)
  • Topamax (8 people, 8.89%)
  • Onfi (7 people, 7.78%)
  • Clonazepam (7 people, 7.78%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

Related studies:

Can you answer these questions?

More questions for: Myoclonic jerks, Weakness, Depakene, Bedridden, Head lag abnormal, Myoclonic epilepsy, Drowsiness, hypersomnia, sleepiness - during the day, somnolence, Keppra

You may be interested in these reviews

More reviews for: Myoclonic jerks, Weakness, Depakene, Bedridden, Head lag abnormal, Myoclonic epilepsy, Drowsiness, hypersomnia, sleepiness - during the day, somnolence, Keppra